Use of wound dressings with soft silicone adhesive technology

North East Wales NHS Trust, Wrexham.
Paediatric nursing 04/2009; 21(3):38-43. DOI: 10.7748/paed2009.
Source: PubMed


To evaluate how pain, during and in-between dressing changes, is affected by the introduction of Mepilex Border Lite, a wound dressing manufactured by Mölnlycke Health Care using Safetac soft silicone adhesive technology, to the treatment of different types of paediatric wounds/skin injuries.
Wounds/skin injuries that met the criteria for inclusion in the study were dressed with Mepilex Border Lite. Patients were followed for six weeks or until their wounds/skin injuries had healed, whichever occurred earlier. At each dressing change, pain severity before and during dressing removal was rated by the patient and the investigator on a scale from zero (no pain at all) to ten (worst pain ever). Other variables measured included: signs of trauma to wound/skin injury and surrounding skin, the proportion of viable/non-viable tissue, the quantity and appearance of exudate, odour, and clinical signs of infection. At the final dressing change, patients and investigators completed questionnaires to rate the dressing performance.
Mean pain severity scores were significantly lower (p < or = 0.003) at the first dressing change than at baseline. Over 99.5 per cent of the Mepilex Border Lite dressing changes were reported to be atraumatic and more than half of the wounds healed within the study period. Conformability, ease of use, ease of removal, patient comfort, and overall experience with the dressing were rated as 'good' to 'very good' at the vast majority of final visit evaluations.
This study provides further evidence of the ability of dressings with Safetac soft silicone adhesive technology to minimise trauma and pain and demonstrates the ability of Mepilex Border Lite to overcome the clinical challenges associated with the use of dressings on the wounds/skin injuries of paediatric patients.

154 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Premature infants require, as part of their care, devices such as monitors and temperature probes to be attached to their skin. However, because of immaturity of the skin, they are especially vulnerable to medical adhesive-related skin injury. This case discusses the application of a hydrocolloid (pectin) barrier between the adhesive surface of a silver reflective patch covering thermistor probe and the neonate's skin resulting in medical adhesive skin injury (epidermal stripping). The use of this pectin barrier proved to be a suitable surface to secure the temperature probe and avoid further medical adhesive-related skin injury.
    Journal of wound, ostomy, and continence nursing: official publication of The Wound, Ostomy and Continence Nurses Society / WOCN 01/2014; 41(3):219-221. DOI:10.1097/WON.0000000000000029 · 1.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Backgound: Wounds of paediatric patients provide a variety of unique challenges to wound care practitioners, not least the pain and sensitivity associated with the use of some of the dressings used in their management. In order to provide the best treatment options, these challenges need to be identified and overcome by using the most appropriate dressings and treatment regimens available. Aims: To evaluate the effect of introducing Mepilex ® Border Lite (Mölnlycke Health Care), an absorbent foam dressing with Safetac ® technology, in the management of paediatric wounds. Methods: Case report data from an observational study that was undertaken on paediatric patients with a variety of wound types are presented. Results: The introduction of dressings with Safetac was associated with significant reductions in pain severity compared with the levels reported with a variety of other dressings that had been previously used. Mepilex Border Lite was also found to have good handling characteristics when used on paediatric wounds. Conclusions: Their ability to minimise dressing-related pain and their handling characteristics makes dressings with Safetac an ideal choice for treating wounds and skin injuries of paediatric patients.
  • [Show abstract] [Hide abstract]
    ABSTRACT: To validate the efficacy of a radiodermatitis management protocol (which involves preventive measures, the application of preventive creams and the use of a non-adhesive, foam dressing with a silicone contact layer) at a radiation oncology department in southern Spain. An observational study was carried out on consecutive patients undergoing radiation therapy for sarcomas, ear nose and throat, breast, cervix and lung cancers, excluding patients with other tumours and those who stopped radiation treatment, or who died during its course. Variables that were assessed included: average healing time, general progression of the injury, degree of trauma caused by removing the dressing, convenience and comfort, patient's aesthetic perception, ease of use for health professionals, adaptability, and the length of time for which the dressing stays in place. 20 patients were included in the study and radiodermatitis was resolved in 100% (20/20). Optimal progression of all lesions was observed. No infections occurred, and the average total healing time ranged from one to two weeks, even during radiation therapy Patients reported a high level of satisfaction with the dressing, which scored highly in terms of convenience and comfort, atraumatic dressing, ease of use, adaptability, patients' aesthetic perception and adhesive durability. Our action protocol is effective in the prevention and treatment of radiodermatitis. We achieved optimal results in the current study, which supports the continued use of the test dressing in our department. Conflict of interest: None.
    Journal of Wound Care 03/2011; 20(3):130-5. DOI:10.12968/jowc.2011.20.3.130 · 1.07 Impact Factor
Show more